Evidence map›Paper›PMID 35067837›Full record

ArticleProbiotics and antimicrobial proteins2023

Lacticaseibacillus paracasei K56 Attenuates High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota in Mice.

Zhonghua Miao, Hanying Zheng, Wei-Hsien Liu, Ruyue Cheng, Hui Lan, Ting Sun, Wen Zhao, Jinxing Li, Xi Shen, Hongwei Li and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Longitudinal associations between PMFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Effects ofFrontiers in nutrition · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Modulatory Effects ofFoods (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Gut microbial change after administration ofFrontiers in endocrinology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Zhonghua Miao *Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People's Republic of China.
Hanying Zheng *School of Public Health, Xiamen University, Xiamen, China.
Wei-Hsien LiuInner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China.
Ruyue ChengDepartment of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People's Republic of China.
Hui LanSchool of Public Health, Xiamen University, Xiamen, China.
Ting SunInner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China.
Wen ZhaoInner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China.
Jinxing LiDepartment of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People's Republic of China.
Xi ShenDepartment of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People's Republic of China.
Hongwei LiSchool of Public Health, Xiamen University, Xiamen, China.
Haotian FengInner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China.
Wei-Lian HungInner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China. liuweixian@yili.com.
Fang HeDepartment of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People's Republic of China. hf18602880124@163.com.
Inner Mongolia Yili Industrial Group (China) · CNSichuan University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the effects of Lacticaseibacillus paracasei K56 (L. paracasei K56) on body weight, body composition, and glycolipid metabolism in mice with high-fat diet-induced obesity and explored the underlying mechanisms. Male C57BL/6J mice were fed a high-fat diet for 8 weeks to induce obesity; then, the obese mice were gavaged with or without L. paracasei K56 for 10 weeks. The body weight, body composition, fat mass, blood lipid, blood glucose, and hormones of the mice were evaluated. Moreover, the fatty acid synthesis (FAS) and peroxisome proliferator-activated receptor γ (PPAR-γ) expressions in the liver were detected via Western blotting. 16S rRNA gene sequencing was adopted to determine the gut microbiota alterations. The high-fat diet successfully induced obesity, as indicated by the abnormal increase in body weight, visceral fat, fat mass, blood lipids, fasting blood glucose, and insulin-resistance. Moreover, the FAS expression in the liver was significantly increased, whereas the PPAR-γ expression was significantly decreased. The relative abundance of Proteobacteria, Actinobacteria and Patescibacteria was also significantly increased, and that of Verrucomicrobia was significantly decreased. However, these indicators of mice supplemented with L. paracasei K56 were significantly opposite to those of obese mice. The Ruminococcuaceae_UCG-013, Akkermansia, Prevotellaceae_UCG-001, Muribaculum, and Lachnospiraceae_NK4A136 groups were significantly negatively correlated with body weight, blood lipids, and blood glucose-related indicators, whereas Coriobacteriaceae_UCG-002, Enterorhabdus, Raoultibacter, Acinetobacter, Romboutsia, Leuconostoc, and Erysipelatoclostridium were significantly positively correlated with these indicators. L. paracasei K56 might be a promising probiotic strain that could effectively slow down the body weight gain, reduce fat accumulation, alleviate insulin-resistance, and restore pancreatic β-cell function in obese mice by regulating the gut microbiota.

Indexed as

Gastrointestinal MicrobiomeInsulin ResistanceInsulinsLacticaseibacillus paracaseiAnimalsBacteriaBlood GlucoseBody WeightDiet, High-FatLacticaseibacillusLipidsMaleMiceMice, Inbred C57BLMice, ObeseObesityBlood GlucoseInsulinsLipidsPeroxisome Proliferator-Activated ReceptorsRNA, Ribosomal, 16SGut microbiotaHigh-fat dietObesityProbiotics

Identifiers

PMID35067837
OpenAlexW4206906526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.